Sickness Absence in Primary Aldosteronism and References: a Longitudinal Cohort Study

Clicks: 2
ID: 338100
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #121 of 121 articles by views in european journal of endocrinology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 121 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Objective Primary aldosteronism (PA) is a common cause of hypertension and is associated with increased cardiovascular morbidity. However, its impact on work capacity remains unknown. We investigated sickness absence and disability pension among patients with PA and in matched reference groups with and without hypertension. Methods A nationwide eight-year longitudinal cohort study based on linked register data, including 838 individuals with PA aged 18–67 in 2019 and two matched reference cohorts with and without hypertension. Outcomes included annual proportions of individuals with sickness absence (in spells >14 days) or disability pension, mean annual net days, and trajectories of absence days. Results Patients with PA had a higher mean annual proportion with sickness absence than individuals with hypertension (21% (range: 18-23%) vs 17% (range: 17-19%) and those without hypertension (10% (range: 9-12%)). Mean annual sickness absence days were 27, 20, and 9, respectively. The combined mean annual number of sickness absence and disability pension days was similar in PA and hypertension (54 (range: 40-66) vs 53 (range: 50-57), and higher than in those without hypertension (25 (range: 22-29)). Trajectory analysis identified four patterns of absence days; 12% of patients with PA had persistently high absence, significantly associated with female sex, higher age, lower education, unmarried status, rural residence, cardiovascular disease, and treatment with mineralocorticoid receptor antagonists. Conclusion PA is associated with substantial and sustained sickness absence and disability pension, comparable to that observed in hypertension and higher than in individuals without hypertension. These findings extend the clinical impact of PA beyond cardiovascular morbidity and highlight the importance of considering work capacity in clinical management. Objective Primary aldosteronism (PA) is a common cause of hypertension and is associated with increased cardiovascular morbidity. However, its impact on work capacity remains unknown. We investigated sickness absence and disability pension among patients with PA and in matched reference groups with and without hypertension. Methods A nationwide eight-year longitudinal cohort study based on linked register data, including 838 individuals with PA aged 18–67 in 2019 and two matched reference cohorts with and without hypertension. Outcomes included annual proportions of individuals with sickness absence (in spells >14 days) or disability pension, mean annual net days, and trajectories of absence days. Results Patients with PA had a higher mean annual proportion with sickness absence than individuals with hypertension (21% (range: 18-23%) vs 17% (range: 17-19%) and those without hypertension (10% (range: 9-12%)). Mean annual sickness absence days were 27, 20, and 9, respectively. The combined mean annual number of sickness absence and disability pension days was similar in PA and hypertension (54 (range: 40-66) vs 53 (range: 50-57), and higher than in those without hypertension (25 (range: 22-29)). Trajectory analysis identified four patterns of absence days; 12% of patients with PA had persistently high absence, significantly associated with female sex, higher age, lower education, unmarried status, rural residence, cardiovascular disease, and treatment with mineralocorticoid receptor antagonists. Conclusion PA is associated with substantial and sustained sickness absence and disability pension, comparable to that observed in hypertension and higher than in individuals without hypertension. These findings extend the clinical impact of PA beyond cardiovascular morbidity and highlight the importance of considering work capacity in clinical management.
Reference Key
openalex_W7150795636 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Óskar Ragnarsson, Alexander Bore, Kristina Alexanderson
Are you one of these authors? Claim your profile
Journal european journal of endocrinology
Year 2026
DOI
10.1093/ejendo/lvag198
URL
https://doi.org/10.1093/ejendo/lvag198
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.